Advanov Pharma Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Advanov Pharma Private Limited Pharmaceutical Export Portfolio Dataset — 3 Products, $452.2K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Advanov Pharma Private Limited — Pharmaceutical Exporter Profile (2026) | 3 Products, $452.2K Trade | TransData Nexus

Advanov Pharma Private Limited

Indian Pharmaceutical Exporter · Medical Devices & Diagnostics Specialist · $452.2K Total Trade · DGFT Verified

Advanov Pharma Private Limited is an Indian pharmaceutical exporter with a total trade value of $452.2K across 3 products in 2 therapeutic categories. Based on 15 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Strip ($300.0K), Reagent ($106.5K), Vinblastine ($45.7K).

Advanov Pharma Private Limited — Export Portfolio & Destination Treemap

Advanov Pharma Private Limited pharmaceutical export portfolio — 3 products across 2 therapeutic categories. Source: Indian Customs (DGFT).

Who is Advanov Pharma Private Limited? — Company Overview & Market Position

Advanov Pharma Private Limited, established on June 12, 2017, is a privately held pharmaceutical company headquartered in Ahmedabad, Gujarat, India. The company is registered under the Corporate Identification Number (CIN) U74999GJ2017PTC097840. As of the latest available data, Advanov Pharma has an authorized capital of ₹2 million and a paid-up capital of ₹100,000. The company's operations are currently active, with its registered office located at 1010, Zion Z1, Near Hotel Avalon, Bodakdev Road, Sindhubhavan, Ahmedabad – 380054, Gujarat.

The company is led by Managing Director Mr. Hemalkumar Rashmikant Shah, who has been with Advanov Pharma since April 18, 2018. Another key executive is Ms. Gayatriben Hemalbhai Shah, serving as a Director since February 6, 2023. Advanov Pharma specializes in the development and export of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, across various therapeutic categories. The company's product portfolio is concentrated, with its top five products accounting for 100% of its export value.

What Does Advanov Pharma Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Strip$300.0K

Product Portfolio — Top 3 by Export Value

Advanov Pharma Private Limited exports 3 pharmaceutical products across 2 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Strip	Medical Devices & Diagnostics	$300.0K	6	0.2%	7
2	Reagent	Medical Devices & Diagnostics	$106.5K	4	0.8%	8
3	Vinblastine	Oncology	$45.7K	5	6.1%	4

Advanov Pharma Private Limited exports 3 pharmaceutical products across 2 therapeutic categories with a total export value of $452.2K. The top category is Medical Devices & Diagnostics (89.9% of portfolio), followed by Oncology (10.1%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Advanov Pharma Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Advanov Pharma Private Limited collaborates with certified manufacturing partners that adhere to stringent quality standards. These facilities are compliant with WHO-GMP, EU-GMP, and USFDA regulations, ensuring the production of high-quality pharmaceutical formulations. The company emphasizes a Just-in-Time inventory strategy, maintaining an updated inventory of regular products to meet client requirements promptly.

3Key Leadership

The leadership team at Advanov Pharma Private Limited is spearheaded by Managing Director Mr. Hemalkumar Rashmikant Shah, who brings over two decades of experience in the pharmaceutical industry. His career includes significant roles at organizations such as Zydus Cadila, GlaxoSmithKline, AstraZeneca, and Johnson & Johnson. Under his guidance, Advanov Pharma has expanded its global footprint, focusing on markets in Latin America, the Commonwealth of Independent States (CIS), Asia, and Africa.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Advanov Pharma Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Advanov Pharma Private Limited has established a presence in several regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company ensures that its manufacturing partners comply with international standards, such as WHO-GMP, EU-GMP, and USFDA regulations, facilitating market access in these regions. While specific regulatory filings and approvals are not detailed in the available sources, the company's adherence to these standards indicates a commitment to meeting the requirements of these markets.

2Emerging Markets

Advanov Pharma Private Limited has strategically expanded its operations into emerging markets across Africa, Latin America, and Southeast Asia. The company has established distribution networks in countries such as Mexico, Colombia, Chile, Panama, Costa Rica, Ecuador, Tanzania, Nigeria, Congo, South Africa, French West Africa, Myanmar, Sri Lanka, Vietnam, and the Philippines. This expansion is supported by partnerships with local channel partners and the establishment of fully owned subsidiaries in select regions, including the Philippines, Sri Lanka, Uzbekistan, and Mexico.

3Geographic Strategy

Advanov Pharma Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific details regarding Advanov Pharma Private Limited's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history are not publicly available in the provided sources. However, the company's emphasis on compliance with USFDA regulations suggests a proactive approach to meeting FDA standards for its pharmaceutical formulations.

2WHO & EU GMP

Advanov Pharma Private Limited ensures that its manufacturing partners adhere to WHO-GMP and EU-GMP standards, reflecting the company's commitment to producing high-quality pharmaceutical products. While specific certifications are not detailed in the available sources, the company's focus on these standards indicates a robust quality assurance framework.

3CDSCO & Indian Regulatory

Advanov Pharma Private Limited operates in compliance with the Central Drugs Standard Control Organisation (CDSCO) regulations and holds the necessary manufacturing licenses and approvals from state drug controllers. The company also obtains export No Objection Certificates (NOCs) as required for international shipments. Specific details regarding these regulatory approvals are not provided in the available sources.

Advanov Pharma Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Advanov Pharma Private Limited operates in a competitive landscape with several key players in the pharmaceutical industry. While specific competitors are not identified in the available sources, the company's focus on high-quality, affordable medicines and its strategic expansion into emerging markets position it to effectively compete in the global pharmaceutical sector.

2Key Differentiators

Advanov Pharma Private Limited differentiates itself through its commitment to producing advanced and novel pharmaceutical products that address unmet patient needs. The company's adherence to stringent manufacturing standards, including WHO-GMP, EU-GMP, and USFDA compliance, ensures the delivery of high-quality formulations. Additionally, its strategic expansion into diverse geographic markets and focus on a Just-in-Time inventory strategy enhance its competitive edge.

3Strategic Position

Advanov Pharma Private Limited's strategic direction encompasses the development and export of finished pharmaceutical formulations across various therapeutic categories, including oncology, ophthalmology, critical care, contrast media, liquid injectables, and medical devices. The company's expansion into emerging markets and focus on high-quality, affordable medicines underscore its commitment to addressing global healthcare needs. Future outlooks suggest continued growth through strategic partnerships, in-licensing, out-licensing, and potential mergers and acquisitions.

Buyer Due Diligence Brief — Evaluating Advanov Pharma Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Advanov Pharma Private Limited maintains a strong track record in the pharmaceutical industry, with a focus on high-quality, affordable medicines. The company's export volume and consistency are supported by its adherence to international manufacturing standards and strategic partnerships across various regions. Reliability indicators include compliance with WHO-GMP, EU-GMP, and USFDA regulations, as well as a Just-in-Time inventory strategy to meet client requirements promptly.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

FDA Approval: Confirm that the manufacturing facility is registered with the US Food and Drug Administration (FDA) and that products have the necessary approvals. Verification can be done through the FDA's official website or by contacting the FDA directly.

WHO-GMP Certification: Ensure that the manufacturing facility holds a valid World Health Organization Good Manufacturing Practice (WHO-GMP) certificate. This can be verified by contacting the World Health Organization or the national regulatory authority.

Frequently Asked Questions — Advanov Pharma Private Limited

How many pharmaceutical products does Advanov Pharma Private Limited export from India?

Advanov Pharma Private Limited exports 3 pharmaceutical products across 2 therapeutic categories. The top exports are Strip ($300.0K), Reagent ($106.5K), Vinblastine ($45.7K). Total export value is $452.2K.

What is Advanov Pharma Private Limited's total pharmaceutical export value?

Advanov Pharma Private Limited's total pharmaceutical export value is $452.2K, based on 15 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Advanov Pharma Private Limited cover?

Advanov Pharma Private Limited exports across 2 therapeutic categories. The largest are Medical Devices & Diagnostics (89.9%, 2 products), Oncology (10.1%, 1 products).

Get Full Advanov Pharma Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.